Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health.
暂无分享,去创建一个
Peter C Austin | Muhammad M Mamdani | Janet E Hux | P. Austin | J. Hux | D. Juurlink | M. Mamdani | David N Juurlink
[1] G H Guyatt,et al. A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.
[2] D. Phillips,et al. Psychology and survival , 1993, The Lancet.
[3] Nick Freemantle,et al. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? , 2001, BMJ : British Medical Journal.
[4] Psychology and survival , 1994, The Lancet.
[5] Predicting incidence of some critical events by sun signs—the Pisces study , 2003 .
[6] J. Cleland,et al. Clinical trials update: OPTIME‐CHF, PRAISE‐2, ALL‐HAT , 2000, European journal of heart failure.
[7] G GordilloPaniagua,et al. The International Committee of Medical Journal Editors , 1981 .
[8] B. Everitt. The Cambridge Dictionary of Statistics , 1998 .
[9] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[10] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[11] M F Huque,et al. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. , 1997, Statistics in medicine.
[12] S. Lange,et al. Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.
[13] P. Rothwell. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.
[14] J. Wittes,et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.
[15] Bertram Pitt,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.
[16] L. J. Anthony,et al. The Cambridge Dictionary of Statistics (2nd ed.) , 2003 .
[17] P. Sleight. Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! , 2000, Current controlled trials in cardiovascular medicine.
[18] John Goodier,et al. The Cambridge Dictionary of Statistics (3rd edition) , 2007 .
[19] Eter,et al. EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART FAILURE , 2000 .
[20] K. Lee,et al. Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group. , 1997, Circulation.
[21] Bertram Pitt,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.
[22] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.